<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02403427</url>
  </required_header>
  <id_info>
    <org_study_id>PBS1/B9/13/2012-I</org_study_id>
    <nct_id>NCT02403427</nct_id>
  </id_info>
  <brief_title>The Expert System VoiceDiab in Children With Diabetes</brief_title>
  <acronym>VoiceDiab</acronym>
  <official_title>The Voice Decision Support Expert System in Basal-bolus Insulin Therapy of Diabetes Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instytut Diabetologii Sp. z o.o.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Centre for Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instytut Diabetologii Sp. z o.o.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to conduct the preliminary investigation on the efficacy and safety
      in terms of postprandial glucose value and the rates of hypoglycaemia when expert VoiceDiab
      system supports patient's decision on prandial insulin programming in insulin pump therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In children with type 1 diabetes glucose deterioration occurred every day and night leading
      into low satisfaction with treatment. Unstable glycemic profile resulting in high glycemic
      variability depends on the adjustment of insulin dosing to the current needs of the organism.
      The calculation of prandial insulin dosing is a complex process which involves such factors
      as preprandial blood glucose level, the amount of food taken, the glycemic index of
      carbohydrates, the insulin/carbohydrate exchange ratio, the active insulin level following
      the previous bolus. Currently, in patients treated with continuous subcutaneous insulin
      infusion (CSII) insulin pumps are equipped with bolus calculators which help to calculate
      prandial insulin dosing and thus contribute to improve post-prandial blood glucose levels.

      The aim of the study was to determine whether the patient's support expert VoiceDiab system
      have stabilised diurnal glucose profile in children with type 1 diabetes treated with insulin
      pumps.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postprandial glucose</measure>
    <time_frame>96 houres</time_frame>
    <description>postprandial glucose with respect the hyperglycaemia above 180 mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC</measure>
    <time_frame>240 mintues after each study's meal</time_frame>
    <description>he Area Under The Curve (AUC) of postprandial glucose level over 240 minutes,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPGE- postprandial glucose excursion</measure>
    <time_frame>96 houres</time_frame>
    <description>Postprandial Glucose Excursions (PPGE), defined as the change in glucose concentration from before the meal to Peak Postprandial Glucose (PPG),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypoglycemia</measure>
    <time_frame>96 houres</time_frame>
    <description>Hypoglycaemic episodes over time of observation measeured by CGM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LBGI</measure>
    <time_frame>96 houres</time_frame>
    <description>Low Blood Glucose Index ( LBGI) - as a one of the glucose variability parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose variability parameters</measure>
    <time_frame>96 houres</time_frame>
    <description>SD total (SDT)- from all days, SD within days (SDw); SD between time points (SDhh:mm); High Blood Glucose Index (HBGI)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>10 days</time_frame>
    <description>Patients well being when VoiceDiab system is implement</description>
  </other_outcome>
  <other_outcome>
    <measure>Patients' acceptances to use VoiceDiab system</measure>
    <time_frame>10 days</time_frame>
    <description>based on the study's questioner</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Type 1 Diabetes Mellitus With Hyperglycemia</condition>
  <condition>Type 1 Diabetes Mellitus With Hypoglycaemia</condition>
  <arm_group>
    <arm_group_label>VoiceDiab expert system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the VoiceDiab system using before every main meal; three times per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>manual calculation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>manula insulin calculation before every main meal; three times per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VoiceDiab expert system</intervention_name>
    <description>Decision support system VoiceDiab this is computer-based system constructed for mobile phone devices working on the server.
Patients in experimental arm get the mobile phone application for 4 days. Glucose control will be done by two methods SMPG and CGM. Before every study's meal insulin dose with type of bolus will be indicate by VoiceDiab.</description>
    <arm_group_label>VoiceDiab expert system</arm_group_label>
    <other_name>patient's decision supporting system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed type 1 diabetes at least 12 month prior screening visit

          -  Current treatment with basal-bolus regime and insulin pump for at least 12 weeks prior
             screening visit.

          -  HbAc &lt; 11%

          -  Ability and willingness to adhere to the protocol including self-management and
             dealing with mobile device.

        Exclusion Criteria:

          -  Multiply daily injection modality,

          -  Treatment with regular insulin,

          -  Use of any anti-diabetic agent,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Ladyzynski, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Biocybernetics and Biomedicin Engineering in Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ewa Pankowska, PhD</last_name>
    <phone>+48226164474</phone>
    <email>pankowskae@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katarzyna Ruszkowska</last_name>
    <phone>+48226164474</phone>
    <email>ruszkowska.kasia@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ewa Pankowska</name>
      <address>
        <city>Warsaw</city>
        <zip>04-736</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Ruszkowska</last_name>
      <phone>+48226164474</phone>
      <email>ruszkowska.kasia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ewa Pankowska, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karolina Mazurczak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Foltynski, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>pubmed</description>
  </link>
  <reference>
    <citation>Pańkowska E, Błazik M, Groele L. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study. Diabetes Technol Ther. 2012 Jan;14(1):16-22. doi: 10.1089/dia.2011.0083. Epub 2011 Oct 20.</citation>
    <PMID>22013887</PMID>
  </reference>
  <reference>
    <citation>Błazik M, Pańkowska E. The education of patients in prandial insulin dosing related to the structure of bolus calculators. Pediatr Endocrinol Diabetes Metab. 2010;16(4):301-5. Review.</citation>
    <PMID>21447273</PMID>
  </reference>
  <reference>
    <citation>Kovatchev BP. Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes. Scientifica (Cairo). 2012;2012:283821. doi: 10.6064/2012/283821. Epub 2012 Oct 17. Review.</citation>
    <PMID>24278682</PMID>
  </reference>
  <reference>
    <citation>McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther. 2006 Dec;8(6):644-53.</citation>
    <PMID>17109596</PMID>
  </reference>
  <results_reference>
    <citation>Błazik M, Pańkowska E. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT. Pediatr Diabetes. 2012 Nov;13(7):534-9. doi: 10.1111/j.1399-5448.2012.00876.x. Epub 2012 May 14.</citation>
    <PMID>22577884</PMID>
  </results_reference>
  <results_reference>
    <citation>Pańkowska E, Błazik M. Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. J Diabetes Sci Technol. 2010 May 1;4(3):571-6.</citation>
    <PMID>20513322</PMID>
  </results_reference>
  <results_reference>
    <citation>Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x. Epub 2008 Oct 20.</citation>
    <PMID>19175902</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2015</study_first_posted>
  <last_update_submitted>May 6, 2015</last_update_submitted>
  <last_update_submitted_qc>May 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instytut Diabetologii Sp. z o.o.</investigator_affiliation>
    <investigator_full_name>Ewa Pankowska</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>Bolus calculator</keyword>
  <keyword>Insulin pump</keyword>
  <keyword>basal-bolus insulin therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

